Novo Nordisk A/s

Boe Technology Group Co., Ltd.

Jinchao Zhang

Jing Su

Petrus Johannes Louis Spee

Jianhe Chen

Jiujiu Yu

Qi Yao

Jing Li

Shi Shu

Ce Ning

Yong Yu

Chuanxiang Xu

Lizhong Wang

Yang Yue

Soren Berg Padkjaer

Shaohui Li

Søren Berg Padkjær

The disclosure provides a liquid crystal display panel and a display apparatus. The liquid crystal display panel of the disclosure includes: first and second substrates assembled to form a cell, a plurality of main spacers therebetween, and an auxiliary spacer around at least a portion of the main spacers. Height of the auxiliary spacer is greater than or equal to that of the main spacer. The display panel further includes: pillows on side of the first substrate close to the second substrate and each abutting against a corresponding main spacer. An orthographic projection of the main spacer on the first substrate falls within an orthographic projection of the pillow on the first substrate, and an orthographic projection of the auxiliary spacer on the first substrate does not overlap with the orthographic projection of the pillow on the first substrate.

Liquid crystal display panel and display apparatus

The present invention relates to agents that are non-competitive antagonists of the CD94/NKG2A receptor such as certain anti-NKG2A antibodies, in particular humanized versions of murine anti-NKG2A antibody Z199, as well as methods of producing and using such agents and antibodies.

Humanized anti-human NKG2A monoclonal antibody

Growing community of inventors

Beijing, China

Jinchao Zhang